Department of Otolaryngology-Head and Neck Surgery, Weill Cornell Medical College, New York, New York, U.S.A.
Weill Cornell Medical College, New York, New York, U.S.A.
Laryngoscope. 2020 Jun;130(6):1558-1564. doi: 10.1002/lary.28316. Epub 2019 Oct 11.
Most patients with vestibular schwannoma (VS) have significant hearing loss in the affected ear as a result of either their tumor or treatment. There is a paucity of data on which hearing rehabilitation options, if any, are preferred by patients with VS. Our study analyzed the use of hearing rehabilitation devices among VS patients.
Patients with unilateral VS treated at our institution from January 2008 to August 2018 were identified. Those with bilateral VS, profound hearing loss in the contralateral ear, neurofibromatosis type 2, or inadequate follow-up were excluded. Patients who met inclusion criteria were given two online questionnaires: an 8-item instrument that assesses use of hearing rehabilitation devices and the Abbreviated Profile of Hearing Aid Benefit.
Of 212 eligible patients, 61 completed both surveys. The majority (88%) were able to hear "poorly" or "not at all" in the affected ear, but less than one-third had ever used a hearing rehabilitation device. Most had used conventional hearing aids (30%) or contralateral routing of signal/bilateral contralateral routing of signal (30%), whereas only a handful had used bone-anchored hearing devices or cochlear implant. Patients who did not pursue hearing rehabilitation were either not bothered by their deficit or were unaware of their options. Most had good functionality despite their deficit.
Whereas 88% of patients treated for VS had a significant hearing loss, the majority did not pursue hearing rehabilitation but maintained good functional performance. Many did not remember being counseled about hearing rehabilitation options, indicating that regular and repeated counseling may be needed to increase patient utilization of hearing rehabilitation after VS treatment.
4 Laryngoscope, 130:1558-1564, 2020.
由于肿瘤或治疗,大多数听神经鞘瘤(VS)患者患侧耳朵存在明显听力损失。关于 VS 患者偏好的听力康复选择的数据很少。我们的研究分析了 VS 患者使用听力康复设备的情况。
我们从 2008 年 1 月至 2018 年 8 月对在我院接受单侧 VS 治疗的患者进行了研究。排除双侧 VS、对侧耳重度听力损失、神经纤维瘤病 2 型或随访不充分的患者。符合纳入标准的患者接受了两项在线问卷调查:一项 8 项评估听力康复设备使用情况的仪器和简化助听器获益量表。
在 212 名符合条件的患者中,有 61 名患者完成了这两项调查。大多数患者(88%)在患病耳中只能听到“差”或“根本听不到”,但不到三分之一的患者曾经使用过听力康复设备。大多数患者使用传统助听器(30%)或对侧信号转导/双侧对侧信号转导(30%),而只有少数患者使用骨导式听力设备或人工耳蜗。未进行听力康复的患者要么对其缺陷不以为意,要么对其选择一无所知。尽管存在听力缺陷,但大多数患者的功能仍良好。
尽管 88%的 VS 治疗患者存在明显的听力损失,但大多数患者并未寻求听力康复,但仍保持良好的功能表现。许多患者不记得曾被建议进行听力康复选择,这表明在 VS 治疗后,为增加患者对听力康复的利用,可能需要定期和反复进行咨询。
4 Laryngoscope, 130:1558-1564, 2020.